Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q4 | $1.6B | -- | -- | $5.22 | -- |
| 10/30/2025 | Q3 | $1.6B | $1.6B | $4.24 | $4.22 | $0.02 |
| 07/31/2025 | Q2 | $1B | $1.1B | $3.18 | $2.68 | $0.50 |
| 04/29/2025 | Q1 | $843.7M | $844.6M | $1.95 | $2.55 | -$0.60 |
| 02/25/2025 | Q4 | $1.5B | $1.5B | $3.65 | $4.73 | -$1.07 |
| 10/29/2024 | Q3 | $1.1B | $887.7M | $2.91 | $3.15 | -$0.24 |
| 07/30/2024 | Q2 | $933.9M | $1B | $3.25 | $2.66 | $0.59 |
| 05/01/2024 | Q1 | $725.3M | $794.1M | $2.20 | $2.02 | $0.18 |
| 02/27/2024 | Q4 | $1.3B | $1.2B | $3.25 | $3.13 | $0.11 |
| 10/31/2023 | Q3 | -- | $801.1M | $2.50 | -- | -- |
| 07/27/2023 | Q2 | -- | $810.7M | $1.59 | -- | -- |
| 04/27/2023 | Q1 | -- | $548.3M | $0.40 | -- | -- |
| 02/28/2023 | Q4 | -- | $1B | -$0.07 | -- | -- |
| 10/27/2022 | Q3 | -- | $628.9M | -$0.46 | -- | -- |
| 07/28/2022 | Q2 | -- | $621M | $0.52 | -- | -- |
| 04/28/2022 | Q1 | -- | $367M | -$0.41 | -- | -- |
| 03/01/2022 | Q4 | -- | $907.3M | $1.23 | -- | -- |
| 11/04/2021 | Q3 | -- | $583.5M | $0.42 | -- | -- |
| 07/29/2021 | Q2 | -- | $629.2M | $0.77 | -- | -- |
| 04/29/2021 | Q1 | -- | $803.4M | $1.96 | -- | -- |
| 02/25/2021 | Q4 | -- | $609.2M | $1.08 | -- | -- |
| 10/27/2020 | Q3 | -- | $927.6M | $1.45 | -- | -- |
| 08/06/2020 | Q2 | -- | $642.4M | $0.35 | -- | -- |
| 05/07/2020 | Q1 | -- | $531.9M | $0.85 | -- | -- |
| 02/20/2020 | Q4 | -- | $1.4B | -$0.56 | -- | -- |
| 10/24/2019 | Q3 | -- | $546.8M | $0.29 | -- | -- |
| 08/01/2019 | Q2 | -- | $584.8M | -$0.18 | -- | -- |
| 05/02/2019 | Q1 | -- | $532M | -$0.64 | -- | -- |
| 02/21/2019 | Q4 | -- | $691.2M | $0.49 | -- | -- |
| 10/25/2018 | Q3 | -- | $676.2M | $0.54 | -- | -- |
| 07/26/2018 | Q2 | -- | $309.3M | -$0.46 | -- | -- |
| 04/26/2018 | Q1 | -- | $567.3M | $0.78 | -- | -- |
| 02/22/2018 | Q4 | -- | $339.2M | -$4.14 | -- | -- |
| 10/26/2017 | Q3 | -- | $1.1B | $1.95 | -- | -- |
| 07/27/2017 | Q2 | -- | $623.3M | $0.50 | -- | -- |
| 05/02/2017 | Q1 | -- | $891.8M | $0.09 | -- | -- |
| 02/21/2017 | Q4 | -- | $330.8M | -$7.30 | -- | -- |
| 11/02/2016 | Q3 | -- | $681.3M | $1.45 | -- | -- |
| 08/03/2016 | Q2 | -- | $1B | -$0.11 | -- | -- |
| 04/27/2016 | Q1 | -- | $876.1M | $1.90 | -- | -- |
| 02/16/2016 | Q4 | -- | $942.3M | $1.60 | -- | -- |
First Solar, Inc. reported $1.6B worth of top line sales in its most recent quarter.
First Solar, Inc. announced earnings per share of $4.24 which represents a beat of analyst forecast a $4.22 per share.
First Solar, Inc. reported $610.7M that represents $5.68 per share over the last quarter.
First Solar, Inc.'s earnings are forecast to grow from $12.02 per share to $13.19 per share next year representing an increase of 21.66%.
First Solar, Inc.'s next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.